PlainRecalls
FDA Drug Moderate Class II Terminated

dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.

Reported: January 5, 2022 Initiated: November 12, 2021 #D-0315-2022

Product Description

dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
SterRx, LLC
Units Affected
8946 bags
Distribution
U.S.A. Nationwide
Location
Plattsburgh, NY

Frequently Asked Questions

What product was recalled?
dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.. Recalled by SterRx, LLC. Units affected: 8946 bags.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 5, 2022. Severity: Moderate. Recall number: D-0315-2022.